MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice

BACKGROUND AND AIMS: Several oncolytic viruses applications have been approved in the clinic or in different phases of clinical trials. However, these methods have some rudimentary problems. Therefore, to enhance the delivery and quality of treatment, considering the advantage of cell carrier-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyed-Khorrami, Seyed-Mahmood, Soleimanjahi, Hoorieh, Soudi, Sara, Habibian, Ala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088007/
https://www.ncbi.nlm.nih.gov/pubmed/33933086
http://dx.doi.org/10.1186/s12935-021-01848-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088007/
https://www.ncbi.nlm.nih.gov/pubmed/33933086
http://dx.doi.org/10.1186/s12935-021-01848-5

Ejemplares similares